Int J Gynaecol Obstet. 2002 Jun;77(3):299-301. doi: 10.1016/s0020-7292(02)90064-0.
Bone mineral density (BMD) testing is an effective approach for the early detection of osteopenia and osteoporosis. The American College of Obstetricians and Gynecologists Committee on Gynecologic Practice recommends BMD testing for all postmenopausal women aged 65 years or older and for all postmenopausal women who present with fractures. The Committee also concludes that BMD testing may be recommended to post-menopausal women younger than 65 years who have one or more risk factors for osteoporosis. Bone mineral density testing also may be useful for pre-menopausal and postmenopausal women who present with certain diseases or medical conditions and those who take certain drugs associated with an increased risk of osteoporosis.
骨密度（BMD）检测是早期发现骨质减少和骨质疏松症的有效方法。美国妇产科医师学会妇科实践委员会建议，对所有65岁及以上的绝经后妇女以及所有出现骨折的绝经后妇女进行骨密度检测。该委员会还得出结论，对于有一个或多个骨质疏松风险因素的65岁以下绝经后妇女，也可建议进行骨密度检测。骨密度检测对于患有某些疾病或病症的绝经前和绝经后妇女以及服用某些与骨质疏松风险增加相关药物的妇女也可能有用。
